Literature DB >> 30149043

Bisphenol A induces Pomc gene expression through neuroinflammatory and PPARγ nuclear receptor-mediated mechanisms in POMC-expressing hypothalamic neuronal models.

Ashkan Salehi1, Neruja Loganathan1, Denise D Belsham2.   

Abstract

Endocrine disrupting chemicals, such as bisphenol A (BPA), have been linked to obesity. However, the direct effect of BPA on the hypothalamic pro-opiomelanocortin (POMC) neurons, which regulate energy homeostasis, remains unexplored. We define the effect of BPA on functionally characterized, POMC-expressing cell models, mHypoA-POMC/GFP-2 and mHypoE-43/5. Exposure to BPA significantly induced the mRNA levels of Pomc in both primary culture and the cell lines. Neuroinflammatory and steroid receptor mRNA levels were assessed to delineate the potential mechanisms, including inflammatory markers Nfκb, Il6 and Iκba, and steroid receptors Esr1, Esr2, Gpr30, Esrrg, and Pparg. Pre-treatment with anti-inflammatory compounds gonadotropin-releasing hormone, and PS1145, an IκB kinase inhibitor, abrogated the BPA-mediated Pomc induction. Furthermore, T0070907, a PPARγ antagonist, abolished Pomc induction, while the GPR30 antagonist G15 had no effect. These findings indicate that BPA may have direct effects on POMC neurons in the hypothalamus, utilizing neuroinflammatory mechanisms and through PPARγ nuclear receptors.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell biology; Endocrine-disrupting; Feeding-regulation; Metabolism; Neuronal cell lines; Neuropeptide

Mesh:

Substances:

Year:  2018        PMID: 30149043     DOI: 10.1016/j.mce.2018.08.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  Bisphenol A Alters Bmal1, Per2, and Rev-Erba mRNA and Requires Bmal1 to Increase Neuropeptide Y Expression in Hypothalamic Neurons.

Authors:  Neruja Loganathan; Ashkan Salehi; Jennifer A Chalmers; Denise D Belsham
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

Review 2.  Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential.

Authors:  Kimberly W Y Mak; Aws F Mustafa; Denise D Belsham
Journal:  Pharmacol Rep       Date:  2022-09-09       Impact factor: 3.919

Review 3.  Are BPA Substitutes as Obesogenic as BPA?

Authors:  Fabiana Oliviero; Alice Marmugi; Catherine Viguié; Véronique Gayrard; Nicole Picard-Hagen; Laila Mselli-Lakhal
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Maternal organophosphate flame-retardant exposure alters offspring feeding, locomotor and exploratory behaviors in a sexually-dimorphic manner in mice.

Authors:  Sabrina N Walley; Elizabeth A Krumm; Ali Yasrebi; Kimberly R Wiersielis; Sarah O'Leary; Taylor Tillery; Troy A Roepke
Journal:  J Appl Toxicol       Date:  2020-10-14       Impact factor: 3.446

5.  Phoenixin Expression Is Regulated by the Fatty Acids Palmitate, Docosahexaenoic Acid and Oleate, and the Endocrine Disrupting Chemical Bisphenol A in Immortalized Hypothalamic Neurons.

Authors:  Emma K McIlwraith; Neruja Loganathan; Denise D Belsham
Journal:  Front Neurosci       Date:  2018-11-15       Impact factor: 4.677

6.  Leptin Modulates the Expression of miRNAs-Targeting POMC mRNA by the JAK2-STAT3 and PI3K-Akt Pathways.

Authors:  Adel Derghal; Julien Astier; Flavie Sicard; Charlène Couturier; Jean-François Landrier; Lourdes Mounien
Journal:  J Clin Med       Date:  2019-12-14       Impact factor: 4.241

Review 7.  Neuro-toxic and Reproductive Effects of BPA.

Authors:  Antonietta Santoro; Rosanna Chianese; Jacopo Troisi; Sean Richards; Stefania Lucia Nori; Silvia Fasano; Maurizio Guida; Elizabeth Plunk; Andrea Viggiano; Riccardo Pierantoni; Rosaria Meccariello
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 8.  Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure.

Authors:  Julie M Hall; Callie W Greco
Journal:  Cells       Date:  2019-12-19       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.